Table 2 Association of clinicopathological features between pre and postmenopausal breast cancer.
Variable | Subcategory (N = 446) | Premenopausal (N = 162) n (%) | Postmenopausal (N = 284) n (%) | P value |
|---|---|---|---|---|
T size (cm) | T1 (n = 108) | 39 (27) | 69 (26) | 0.860 |
T2 (n = 253) | 88 (60) | 165 (63) | ||
T3 (n = 49) | 19 (13) | 30 (11) | ||
LN status | Positive (n = 274) | 105 (65) | 169 (60) | 0.268 |
Negative (n = 172) | 57 (35) | 115 (40) | ||
Grade | I (n = 30) | 9 (7) | 21 (8) | 0.525 |
II (n = 186) | 61(45) | 125 (49) | ||
III (n = 175) | 66 (48) | 109 (43) | ||
TILs | Present (n = 204) | 81 (57) | 123 (50) | 0.136 |
Absent (n = 185) | 60 (43) | 125 (50) | ||
ER | Positive (n = 284) | 93 (57) | 191 (67) | 0.038 |
Negative (162) | 69 (43) | 93 (33) | ||
PGR | Positive (n = 265) | 93 (57) | 172 (61) | 0.514 |
Negative (n = 181) | 69 (43) | 112 (39) | ||
HER2 | Positive (n = 86) | 37 (23) | 49 (17) | 0.353 |
Negative (n = 307) | 107 (66) | 200 (70) | ||
Equivocal (n = 53) | 18 (11) | 35 (13) | ||
Subtype | HR + (n = 253) | 77 (47) | 176 (62) | 0.012 |
HER2 (n = 86) | 37 (23) | 49 (17) | ||
TNBC (n = 107) | 48 (30) | 59 (21) |
